The Expression and Prognosis of Caspase-9 in Hepatocellular Carcinoma

Objective: We aim to investigate the expression of Caspase-9 and its prognostic significance in hepatocellular carcinoma (HCC). Methods: The expression of Caspase-9 in 108 specimens of HBV-related HCC, 30 cases of cirrhosis tissue and 20 cases of normal liver tissue was examined by immunohistochemical staining. And we explored the relationship of Caspase-9 with clinicopathological parameters, 5-year overall survival (OS) and disease-free survival (DFS) in HCC patients. Results: Caspase-9 expression in HCC was significantly higher than that in normal liver tissue (χ2 = 4.349, P = 0.037). The expression of Caspase-9 was not different both between normal liver tissue and cirrhosis, cirrhosis and HCC (χ2 = 0.347, P = 0.556; χ2 = 2.713, P = 0.100). Caspase-9 expression in HCC was correlated with Edmondson grade and satellite nodule (P = 0.001 and P = 0.005, respectively). Survival analysis showed that Caspase-9 expression was associated with OS and DFS (P = 0.001 and P = 0.006, respectively). Conclusion: The expression of Caspase-9 correlated with the carcinogenesis and progression of HCC. Assessment the expression of Caspase-9 may predict the recurrence and survival of HCC patients.

[1]  B. Liu,et al.  Chrysin induces cell apoptosis via activation of the p53/Bcl-2/caspase-9 pathway in hepatocellular carcinoma cells. , 2016, Experimental and therapeutic medicine.

[2]  Muer Che-e.  Study on the relationship between degrees of caspase9 protein expression in primary colon cancer and inflammation around the tumor , 2014 .

[3]  Gu Xiaodon.  Expression of Caspase-9 and Survivin in hepatocellular carcinoma tissues and its clinical significance , 2014 .

[4]  Yu Yao-jun.  Expression and role of Caspase-9 in thyroid carcinoma and thyroid benign tumor , 2013 .

[5]  L. Wang,et al.  Downregulation of caspase‐9 is a frequent event in patients with stage II colorectal cancer and correlates with poor clinical outcome , 2010, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[6]  Tara L. Kieffer,et al.  Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis , 2009 .

[7]  Wang You-de.  Expressions of survivin and caspase-9 in human primary hepatocellular carcinoma tissues and their significances , 2009 .

[8]  Ren Su-qin.  The Expression and Clinical Significance of NF-κB and Caspase-9 in Pancreatic Carcinoma , 2007 .

[9]  D. Šuput,et al.  Overexpression of caspase-9 triggers its activation and apoptosis in vitro. , 2006, Croatian medical journal.

[10]  G. Salvesen,et al.  Caspases: keys in the ignition of cell death. , 2002, Chemical reviews.

[11]  Xuejun Jiang,et al.  Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. , 2002, Molecular cell.

[12]  Scott W. Lowe,et al.  Apoptosis A Link between Cancer Genetics and Chemotherapy , 2002, Cell.

[13]  R. Liddington,et al.  Dimer formation drives the activation of the cell death protease caspase 9 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Dong-Liang Yang,et al.  Analysis of in vivo patterns of caspase 3 gene expression in primary hepatocellular carcinoma and its relationship to p21(WAF1) expression and hepatic apoptosis. , 2000, World journal of gastroenterology.

[15]  G. Gores,et al.  Apoptosis and liver disease. , 2000, The American journal of medicine.

[16]  S. Lyons,et al.  Apoptosis and carcinogenesis. , 1999, British medical bulletin.